MALDI reveals membrane lipid profile reversion in MDX mice

Area of Science:

• Biochemistry
• Molecular Biology
• Muscle Physiology

Background:

• Duchenne muscular dystrophy (DMD) is a severe X-linked myopathy caused by dystrophin deficiency.
• Skeletal muscle lipid profiles in mdx mice (DMD model) show altered phosphatidylcholine (PC34:2/PC34:1) ratios.
• Nitric oxide (NO) donors are investigated as a potential therapeutic strategy for DMD.

Purpose of the Study:

• To confirm the structure of specific phospholipids (PC34:2 and PC34:1) using tandem mass spectrometry.
• To evaluate the effect of a nitric oxide donor (molsidomine) on the lipid profile of mdx mouse skeletal muscle.
• To assess the impact of molsidomine treatment on muscle regeneration in mdx mice.

Main Methods:

• In situ Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry (MALDI-MS) for lipid analysis.
• Tandem mass spectrometry for phospholipid structure confirmation.
• Immunohistology to evaluate muscle regeneration processes.

Main Results:

• Confirmed the structural identity of PC34:2 and PC34:1 phospholipids.
• Molsidomine treatment of mdx mice normalized the PC34:2/PC34:1 ion intensity ratio, indicating restored membrane lipid composition.
• Immunohistology revealed an increased muscle regeneration process in treated mdx mice.

Conclusions:

• The inversion of the PC34:2/PC34:1 ratio serves as a biomarker for membrane structural integrity in DMD.
• Molsidomine, an NO donor, effectively restores skeletal muscle lipid composition towards a wild-type profile in mdx mice.
• NO-mediated restoration of lipid profiles is associated with enhanced muscle regeneration, suggesting therapeutic potential for DMD.